You might also read
Articles linked to this work by shared authors, journal, and citation graph.
An educational program successfully shifted hospital use from albumin to hetastarch, reducing plasma volume expander costs. Clinicians must monitor hetastarch for adverse effects, especially in patients with coagulopathies.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: